University of Miami, Sylvester Comprehensive Cancer Center

Site:	University of Miami, Sylvester Comprehensive Cancer Center			Go to their website
Address:	1475 Northwest 12th Ave
City:	Miami
State:	FL
Zip:	33136
Country:	USA

28 trials at this site

Phase	Trial	Trial Status [desc]	Site Status	Drug	NCT#
3	A Phase 3 Study of Ripretinib vs Sunitinib in Patients With Advanced GIST With Specific KIT Exon Mutations Who Were Previously Treated With Imatinib (INSIGHT)	Active, not recruiting	Closed	Ripretinib	NCT05734105
2	Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas	Active, not recruiting	Closed	Axitinib + Pembrolizumab	NCT02636725
2	Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)	Active, not recruiting	Closed	Rogaratinib	NCT04595747
2	Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study	Active, not recruiting	Closed	CB-839	NCT03872427
2	SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST	Active, not recruiting	Closed	Bezuclastinib plus Sunitinib	NCT06208748
1	(NAVIGATOR) Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors	Active, not recruiting	Closed	BLU-285	NCT02508532
1	A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies	Active, not recruiting	Closed	QINLOCK Ripretinib DCC-2618	NCT02571036
1	A Trial of PT2977 Tablets In Patients With Advanced Solid Tumors	Active, not recruiting	Closed	PT2977	NCT02974738